Biopharmaceutical Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030

Biopharmaceutical Market

Industry:  Life Sciences & Healthcare | Publish Date: May 2022 | No of Pages:  277 | No. Tables:  332 | No. Figures:  162

Market Definition:

The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030.

Biopharmaceutical products are produced in living organisms including white blood cells or bacteria. Biopharmaceuticals include vaccines, somatic cells, blood components, allergenic, gene therapies, and recombinant therapeutic protein among others. Intravenous, subcutaneous injections and intramuscular are commonly used ways of delivering biopharmaceuticals. Among these, subcutaneous injections are mostly preferred as they require minimal skills and are least invasive. Intramuscular injections are commonly used for vaccines.

Market Dynamics and Trends:

Surging incidences of chronic diseases such as cancer, cardiovascular diseases (CVDs), and diabetes, among others is one of the key factors driving the demand for biopharmaceuticals. Also, rapid changes in societal behavior coupled with growth in aging population are resulting into a surge in chronic diseases. Moreover, growing middle class population and rapid urbanization, leads to people adopting a more sedentary lifestyle. This results in higher obesity rates and diseases such as diabetes and CVDs upward.

For instance, around 17.9 million people die every year globally due to cardiovascular diseases, followed by cancer at 9.3 million and respiratory diseases at 4.1 million. In addition to this, rising cancer prevalence in developing economies of Asia Pacific coupled with high consumption of alcohol & tobacco bolsters the industry growth during the review period.

Moreover, high R&D investments plays a critical role in the growth of biopharmaceutical industry. Increasing number of epidemics, changing disease rate, less immunity, and poor efficacy of some drugs creates a robust demand for product innovation, thus R&D helps in creating ample opportunities to the market players.

However, high cost associated with biopharmaceutical drug production is one of the key factors hampering the market growth during the review period. Biopharmaceutical drugs are complex mixtures that comprises of whole cells or derivatives from human, plant, animal, or micro-organism sources, and thus results in expensive manufacturing process of biologics.

 

Market Segmentations and Scope of the Study:

The biopharmaceuticals market is segmented on the basis of product, application, and geography. On the basis of product, the market is divided into monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone, and others. On the basis of application, the market is categorized into oncology, blood disorder, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology, and others. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

 

Geographical Analysis:

North America holds the lion share of biopharmaceuticals market during the forecast period. This is attributed to factors such as strong intellectual property system that encourages innovation through data & patent protection, large presence of scientific research base supported by academic organizations and government research funding, and venture capital investments in start-up biopharmaceutical companies. It has one of the most supportive domestic environments for the production & commercialization of pharmaceuticals with minimal market barriers. Also, presence of major key players such as Pfizer, Johnson & Johnson, and Merck, among others, boosts the market growth in this region.

The Asia Pacific market is likely to register a fastest CAGR in the biopharmaceuticals industry on account of increasing prevalence of cancer, heart diseases, and obesity. In addition to this, rising spending on R&D activities to develop innovate biopharmaceutical products, particularly in China, India, and Japan further augment the regional market growth during the assessment period.

 

Competitive Landscape:

The biopharmaceuticals market comprising of various market players such as Abbott Laboratories, Amgen Inc., Biogen, Lilly, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk, Pfizer Inc., Safoni, AstraZeneca, and Moderna.  These market players are adopting various strategies such as agreement, joint venture, and product innovations across various regions to maintain their dominance in the biopharmaceuticals market.

For instance, in March 2021, Abbott announced that its team of scientists from Abbott, Johns Hopkins, National Institute of Allergy and Infectious Diseases, University of Missouri have found that the prevalence of HIV elite controllers was 2.7- 4.3% in population from democratic Republic of Congo (DRC). Moreover, in September 2020, Elliy Lilly & Company and Amgen formed a joint venture for manufacturing of COVID-19 therapies. The products were considered for manufacturing are neutralizing antibodies including LY-CoV-555.

KEY BENEFITS:

  • The biopharmaceuticals market report provides the quantitative analysis of the current market and estimations through 2021-2030 that assists in identifying the prevailing market opportunities to capitalize on. 2019 is the historical year and 2020 is the base year.

  • The study comprises a deep dive analysis of the biopharmaceuticals market trend including the current and future trends for depicting the prevalent investment pockets in the market.

  • The information related to key drivers, restraints and opportunities and their impact on the biopharmaceuticals market is provided in the report.

  • The competitive analysis of the market players along with their market share in the biopharmaceuticals market

  • The SWOT analysis and Porters Five Forces model is elaborated in the study.

  • Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Product

  • Monoclonal antibody

  • Interferon

  • Insulin

  • Growth and coagulation factor

  • Erythropoietin

  • Vaccine

  • Hormone

  • Others

By Application

  • Oncology

  • Blood Disorder

  • Metabolic Disease

  • Infectious Disease

  • Cardiovascular Disease

  • Neurological Disease

  • Immunology

  • Others

By Geography

  • North America

    • U.S

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

    • Singapore

    • Indonesia

    • Rest of Asia-Pacific

  • RoW

    • Latin America

    • Middle East

    • Africa

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2021–2030

Base Year Considered

2021

Forecast Period

2022–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Spain, Italy, Netherlands, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific), Rest of the World (Latin America, Middle East, Africa)

Companies Profiled

Abbott Laboratories, Amgen Inc., Biogen, Lilly, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk, Pfizer Inc., Safoni, AstraZeneca, and Moderna.

column chart pie chart

1.... INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Who should read this REPORT?

1.3.           KEY MARKET SEGMENTS

1.4.           Research Methodology

1.4.1             Secondary Research

1.4.2             Data Analysis Framework

1.4.3             Market size estimation

1.4.4             Forecasting

1.4.5             Primary Research and Data Validation

2.... Biopharmaceutical Market – Executive Summary

2.1.           Market Snapshot, 2020 - 2030, Million USD

3.... MARKET OVERVIEW

3.1.           MARKET DEFINITION AND SCOPE

3.2.           MARKET DYNAMICS

3.2.1             Drivers

3.2.1.1        High prevalence of chronic diseases across the globe

3.2.1.2        Strong adoption of biopharmaceuticals in developing economies

3.2.2             Restraints

3.2.2.1        High cost associated with drug development and the threat of failure

3.2.3             Opportunities

3.2.3.1        Increasing R&D investments

4.... Covid-19 Analysis

4.1.           Impact of COVID-19 on Biopharmaceuticals Market

5.... Market Share ANALYSIS

5.1.           Market share analysis of top 10 Biopharmaceutical Providers, 2020

6.... Global Biopharmaceuticals Market, By Product

6.1.           Overview

6.2.           Monoclonal antibody

6.2.1             Monoclonal antibody Market, By Region

6.2.1.1        North America Monoclonal antibody Market, By Country

6.2.1.2        Europe Monoclonal antibody Market, By Country

6.2.1.3        Asia-Pacific Monoclonal antibody Market, By Country

6.2.1.4        Rest of the World Monoclonal antibody Market, By Country

6.3.           Interferon

6.3.1             Interferon Market, By Region

6.3.1.1        North America Interferon Market, By Country

6.3.1.2        Europe Interferon Market, By Country

6.3.1.3        Asia-Pacific Interferon Market, By Country

6.3.1.4        Rest of the World Interferon Market, By Country

6.4.           Insulin

6.4.1             Insulin Market, By Region

6.4.1.1        North America Insulin Market, By Country

6.4.1.2        Europe Insulin Market, By Country

6.4.1.3        Asia-Pacific Insulin Market, By Country

6.4.1.4        Rest of the World Insulin Market, By Country

6.5.           Growth and Coagulation Factor

6.5.1             Growth and Coagulation Factor Market, By Region

6.5.1.1        North America Growth and Coagulation Factor Market, By Country

6.5.1.2        Europe Growth and Coagulation Factor Market, By Country

6.5.1.3        Asia-Pacific Growth and Coagulation Factor Market, By Country

6.5.1.4        Rest of the World Growth and Coagulation Factor Market, By Country

6.6.           Erythropoietin

6.6.1             Erythropoietin Market, By Region

6.6.1.1        North America Erythropoietin Market, By Country

6.6.1.2        Europe Erythropoietin Market, By Country

6.6.1.3        Asia-Pacific Erythropoietin Market, By Country

6.6.1.4        Rest of the World Erythropoietin Market, By Country

6.7.           Vaccine

6.7.1             Vaccine Market, By Region

6.7.1.1        North America Vaccine Market, By Country

6.7.1.2        Europe Vaccine Market, By Country

6.7.1.3        Asia-Pacific Vaccine Market, By Country

6.7.1.4        Rest of the World Vaccine Market, By Country

6.8.           Hormone

6.8.1             Hormone Market, By Region

6.8.1.1        North America Hormone Market, By Country

6.8.1.2        Europe Hormone Market, By Country

6.8.1.3        Asia-Pacific Hormone Market, By Country

6.8.1.4        Rest of the World Hormone Market, By Country

6.9.           Others

6.9.1             Others  Market, By Region

6.9.1.1        North America Others  Market, By Country

6.9.1.2        Europe Others  Market, By Country

6.9.1.3        Asia-Pacific Others  Market, By Country

6.9.1.4        Rest of the World Others  Market, By Country

7.... Global Biopharmaceuticals Market, By Application

7.1.           Overview

7.2.           Oncology

7.2.1             Oncology Market, By Region

7.2.1.1        North America Oncology Market, By Country

7.2.1.2        Europe Oncology Market, By Country

7.2.1.3        Asia-Pacific Oncology Market, By Country

7.2.1.4        Rest of the World Oncology Market, By Country

7.3.           Blood Disorder

7.3.1             Blood Disorder Market, By Region

7.3.1.1        North America Blood Disorder Market, By Country

7.3.1.2        Europe Blood Disorder Market, By Country

7.3.1.3        Asia-Pacific Blood Disorder Market, By Country

7.3.1.4        Rest of the World Blood Disorder Market, By Country

7.4.           Metabolic Disease

7.4.1             Metabolic Disease Market, By Region

7.4.1.1        North America Metabolic Disease Market, By Country

7.4.1.2        Europe Metabolic Disease Market, By Country

7.4.1.3        Asia-Pacific Metabolic Disease Market, By Country

7.4.1.4        Rest of the World Metabolic Disease Market, By Country

7.5.           Infectious Disease

7.5.1             Infectious Disease Market, By Region

7.5.1.1        North America Infectious Disease Market, By Country

7.5.1.2        Europe Infectious Disease Market, By Country

7.5.1.3        Asia-Pacific Infectious Disease Market, By Country

7.5.1.4        Rest of the World Infectious Disease Market, By Country

7.6.           Cardiovascular Disease

7.6.1             Cardiovascular Disease Market, By Region

7.6.1.1        North America Cardiovascular Disease Market, By Country

7.6.1.2        Europe Cardiovascular Disease Market, By Country

7.6.1.3        Asia-Pacific Cardiovascular Disease Market, By Country

7.6.1.4        Rest of the World Cardiovascular Disease Market, By Country

7.7.           Neurological Disease

7.7.1             Neurological Disease Market, By Region

7.7.1.1        North America Neurological Disease Market, By Country

7.7.1.2        Europe Neurological Disease Market, By Country

7.7.1.3        Asia-Pacific Neurological Disease Market, By Country

7.7.1.4        Rest of the World Neurological Disease Market, By Country

7.8.           Immunology

7.8.1             Immunology Market, By Region

7.8.1.1        North America Immunology Market, By Country

7.8.1.2        Europe Immunology Market, By Country

7.8.1.3        Asia-Pacific Immunology Market, By Country

7.8.1.4        Rest of the World Immunology Market, By Country

7.9.           Other Diseases

7.9.1             Other Diseases Market, By Region

7.9.1.1        North America Other Diseases Market, By Country

7.9.1.2        Europe Other Diseases Market, By Country

7.9.1.3        Asia-Pacific Other Diseases Market, By Country

7.9.1.4        Rest of the World Other Diseases Market, By Country

8.... Global Biopharmaceuticals Market, By Region

8.1.           Overview

8.2.           North America

8.2.1             North America Biopharmaceuticals Market, By Product

8.2.2             North America Biopharmaceuticals Market, By Application

8.2.3             North America Biopharmaceuticals Market, By Country

8.2.3.1        U.S.

8.2.3.1.1        U.S. Biopharmaceuticals Market, By Product

8.2.3.1.2        U.S. Biopharmaceuticals Market, By Application

8.2.3.2        Canada

8.2.3.2.1        Canada Biopharmaceuticals Market, By Product

8.2.3.2.2        Canada Biopharmaceuticals Market, By Application

8.2.3.3        Mexico

8.2.3.3.1        Mexico Biopharmaceuticals Market, By Product

8.2.3.3.2        Mexico Biopharmaceuticals Market, By Application

8.3.           Europe

8.3.1             Europe Biopharmaceuticals Market, By Product

8.3.2             Europe Biopharmaceuticals Market, By Application

8.3.3             Europe Biopharmaceuticals Market, By Country

8.3.3.1        UK

8.3.3.1.1        UK Biopharmaceuticals Market, By Product

8.3.3.1.2        UK Biopharmaceuticals Market, By Application

8.3.3.2        Germany

8.3.3.2.1        Germany Biopharmaceuticals Market, By Product

8.3.3.2.2        Germany Biopharmaceuticals Market, By Application

8.3.3.3        France

8.3.3.3.1        France Biopharmaceuticals Market, By Product

8.3.3.3.2        France Biopharmaceuticals Market, By Application

8.3.3.4        Spain

8.3.3.4.1        Spain Biopharmaceuticals Market, By Product

8.3.3.4.2        Spain Biopharmaceuticals Market, By Application

8.3.3.5        Italy

8.3.3.5.1        Italy Biopharmaceuticals Market, By Product

8.3.3.5.2        Italy Biopharmaceuticals Market, By Application

8.3.3.6        Netherlands

8.3.3.6.1        Netherlands Biopharmaceuticals Market, By Product

8.3.3.6.2        Netherlands Biopharmaceuticals Market, By Application

8.3.3.7        Rest of Europe

8.3.3.7.1        Rest of Europe Biopharmaceuticals Market, By Product

8.3.3.7.2        Rest of Europe Biopharmaceuticals Market, By Application

8.4.           Asia-Pacific

8.4.1             Asia-Pacific Biopharmaceuticals Market, By Product

8.4.2             Asia-Pacific Biopharmaceuticals Market, By Application

8.4.3             Asia-Pacific Biopharmaceuticals Market, By Country

8.4.3.1        China

8.4.3.1.1        China Biopharmaceuticals Market, By Product

8.4.3.1.2        China Biopharmaceuticals Market, By Application

8.4.3.2        Japan

8.4.3.2.1        Japan Biopharmaceuticals Market, By Product

8.4.3.2.2        Japan Biopharmaceuticals Market, By Application

8.4.3.3        India

8.4.3.3.1        India Biopharmaceuticals Market, By Product

8.4.3.3.2        India Biopharmaceuticals Market, By Application

8.4.3.4        Australia

8.4.3.4.1        Australia Biopharmaceuticals Market, By Product

8.4.3.4.2        Australia Biopharmaceuticals Market, By Application

8.4.3.5        South Korea

8.4.3.5.1        South Korea Biopharmaceuticals Market, By Product

8.4.3.5.2        South Korea Biopharmaceuticals Market, By Application

8.4.3.6        Singapore

8.4.3.6.1        Singapore Biopharmaceuticals Market, By Product

8.4.3.6.2        Singapore Biopharmaceuticals Market, By Application

8.4.3.7        Indonesia

8.4.3.7.1        Indonesia Biopharmaceuticals Market, By Product

8.4.3.7.2        Indonesia Biopharmaceuticals Market, By Application

8.4.3.8        Rest of Asia-Pacific

8.4.3.8.1        Rest of Asia-Pacific Biopharmaceuticals Market, By Product

8.4.3.8.2        Rest of Asia-Pacific Biopharmaceuticals Market, By Application

8.5.           Rest of the World

8.5.1             Rest of the World Biopharmaceuticals Market, By Product

8.5.2             Rest of the World Biopharmaceuticals Market, By Application

8.5.3             Rest of the World Biopharmaceuticals Market, By Country

8.5.3.1        Latin America

8.5.3.1.1        Latin America Biopharmaceuticals Market, By Product

8.5.3.1.2        Latin America Biopharmaceuticals Market, By Application

8.5.3.2        Middle East

8.5.3.2.1        Middle East Biopharmaceuticals Market, By Product

8.5.3.2.2        Middle East Biopharmaceuticals Market, By Application

8.5.3.3        Africa

8.5.3.3.1        Africa Biopharmaceuticals Market, By Product

8.5.3.3.2        Africa Biopharmaceuticals Market, By Application

9.... COMPANY PROFILES

9.1.           ABBOTT LABORATORIES

9.1.1             COMPANY OVERVIEW

9.1.2             COMPANY SNAPSHOT

9.1.3             OPERATING BUSINESS SEGMENTS

9.1.4             PRODUCT PORTFOLIO

9.1.5             BUSINESS PERFORMANCE

9.1.6             SALES BY BUSINESS SEGMENT

9.1.7             SALES BY GEOGRAPHIC SEGMENT

9.1.8             KEY STRATEGIC MOVES & DEVELOPMENTS

9.1.9             Primary Market Competitors

9.2.           Amgen Inc

9.2.1             COMPANY OVERVIEW

9.2.2             COMPANY SNAPSHOT

9.2.3             PRODUCT PORTFOLIO

9.2.4             BUSINESS PERFORMANCE

9.2.5             SALES BY GEOGRAPHIC SEGMENT

9.2.6             KEY STRATEGIC MOVES & DEVELOPMENTS

9.2.7             Primary Market Competitors

9.3.           Biogen

9.3.1             COMPANY OVERVIEW

9.3.2             COMPANY SNAPSHOT

9.3.3             PRODUCT PORTFOLIO

9.3.4             BUSINESS PERFORMANCE

9.3.5             SALES BY GEOGRAPHIC SEGMENT

9.3.6             KEY STRATEGIC MOVES & DEVELOPMENTS

9.3.7             Primary Market Competitors

9.4.           Lilly

9.4.1             COMPANY OVERVIEW

9.4.2             COMPANY SNAPSHOT

9.4.3             PRODUCT PORTFOLIO

9.4.4             BUSINESS PERFORMANCE

9.4.5             SALES BY GEOGRAPHIC SEGMENT

9.4.6             KEY STRATEGIC MOVES & DEVELOPMENTS

9.4.7             Primary Market Competitors

9.5.           F. Hoffmann-La Roche Ltd

9.5.1             COMPANY OVERVIEW

9.5.2             COMPANY SNAPSHOT

9.5.3             OPERATING BUSINESS SEGMENTS

9.5.4             PRODUCT PORTFOLIO

9.5.5             BUSINESS PERFORMANCE

9.5.6             SALES BY BUSINESS SEGMENT

9.5.7             SALES BY GEOGRAPHIC SEGMENT

9.5.8             KEY STRATEGIC MOVES & DEVELOPMENTS

9.5.9             Primary Market Competitors

9.6.           Johnson & Johnson Services, Inc.

9.6.1             COMPANY OVERVIEW

9.6.2             COMPANY SNAPSHOT

9.6.3             OPERATING BUSINESS SEGMENTS

9.6.4             PRODUCT PORTFOLIO

9.6.5             BUSINESS PERFORMANCE

9.6.6             SALES BY BUSINESS SEGMENT

9.6.7             SALES BY GEOGRAPHIC SEGMENT

9.6.8             KEY STRATEGIC MOVES & DEVELOPMENTS

9.6.9             Primary Market Competitors

9.7.           Merck & Co., Inc

9.7.1             COMPANY OVERVIEW

9.7.2             COMPANY SNAPSHOT

9.7.3             OPERATING BUSINESS SEGMENTS

9.7.4             PRODUCT PORTFOLIO

9.7.5             BUSINESS PERFORMANCE

9.7.6             SALES BY BUSINESS SEGMENT

9.7.7             SALES BY GEOGRAPHIC SEGMENT

9.7.8             KEY STRATEGIC MOVES & DEVELOPMENTS

9.7.9             Primary Market Competitors

9.8.           Novo Nordisk A/S

9.8.1             COMPANY OVERVIEW

9.8.2             COMPANY SNAPSHOT

9.8.3             OPERATING BUSINESS SEGMENTS

9.8.4             PRODUCT PORTFOLIO

9.8.5             BUSINESS PERFORMANCE

9.8.6             SALES BY BUSINESS SEGMENT

9.8.7             SALES BY GEOGRAPHIC SEGMENT

9.8.8             KEY STRATEGIC MOVES & DEVELOPMENTS

9.8.9             Primary Market Competitors

9.9.           Pfizer Inc

9.9.1             COMPANY OVERVIEW

9.9.2             COMPANY SNAPSHOT

9.9.3             PRODUCT PORTFOLIO

9.9.4             BUSINESS PERFORMANCE

9.9.5             SALES BY GEOGRAPHIC SEGMENT

9.9.6             KEY STRATEGIC MOVES & DEVELOPMENTS

9.9.7             Primary Market Competitors

9.10.         Sanofi

9.10.1           COMPANY OVERVIEW

9.10.2           COMPANY SNAPSHOT

9.10.3           OPERATING BUSINESS SEGMENTS

9.10.4           PRODUCT PORTFOLIO

9.10.5           BUSINESS PERFORMANCE

9.10.6           SALES BY BUSINESS SEGMENT

9.10.7           SALES BY GEOGRAPHIC SEGMENT

9.10.8           KEY STRATEGIC MOVES & DEVELOPMENTS

9.10.9           Primary Market Competitors

9.11.         AstraZeneca

9.11.1           COMPANY OVERVIEW

9.11.2           COMPANY SNAPSHOT

9.11.3           PRODUCT PORTFOLIO

9.11.4           BUSINESS PERFORMANCE

9.11.5           SALES BY GEOGRAPHIC SEGMENT

9.11.6           KEY STRATEGIC MOVES & DEVELOPMENTS

9.11.7           Primary Market Competitors

9.12.         Moderna, Inc.

9.12.1           COMPANY OVERVIEW

9.12.2           COMPANY SNAPSHOT

9.12.3           PRODUCT PORTFOLIO

9.12.4           BUSINESS PERFORMANCE

9.12.5           Primary Market Competitors

LIST OF TABLES

TABLE 1.       Global Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 2.       Global Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 3.       Monoclonal antibody Market Value, By Region, 2020-2025, Million USD

TABLE 4.       Monoclonal antibody Market Value, By Region, 2026-2030, Million USD

TABLE 5.       North America Monoclonal antibody Market Value, By Country, 2020-2025, Million USD

TABLE 6.       North America Monoclonal antibody Market Value, By Country, 2026-2030, Million USD

TABLE 7.       Europe Monoclonal antibody Market Value, By Country, 2020-2025, Million USD

TABLE 8.       Europe Monoclonal antibody Market Value, By Country, 2026-2030, Million USD

TABLE 9.       Asia-Pacific Monoclonal antibody Market Value, By Country, 2020-2025, Million USD

TABLE 10.    Asia-Pacific Monoclonal antibody Market Value, By Country, 2026-2030, Million USD

TABLE 11.    Rest of the World Monoclonal antibody Market Value, By Country, 2020-2025, Million USD

TABLE 12.    Rest of the World Monoclonal antibody Market Value, By Country, 2026-2030, Million USD

TABLE 13.    Interferon Market Value, By Region, 2020-2025, Million USD

TABLE 14.    Interferon Market Value, By Region, 2026-2030, Million USD

TABLE 15.    North America Interferon Market Value, By Country, 2020-2025, Million USD

TABLE 16.    North America Interferon Market Value, By Country, 2026-2030, Million USD

TABLE 17.    Europe Interferon Market Value, By Country, 2020-2025, Million USD

TABLE 18.    Europe Interferon Market Value, By Country, 2026-2030, Million USD

TABLE 19.    Asia-Pacific Interferon Market Value, By Country, 2020-2025, Million USD

TABLE 20.    Asia-Pacific Interferon Market Value, By Country, 2026-2030, Million USD

TABLE 21.    Rest of the World Interferon Market Value, By Country, 2020-2025, Million USD

TABLE 22.    Rest of the World Interferon Market Value, By Country, 2026-2030, Million USD

TABLE 23.    Insulin Market Value, By Region, 2020-2025, Million USD

TABLE 24.    Insulin Market Value, By Region, 2026-2030, Million USD

TABLE 25.    North America Insulin Market Value, By Country, 2020-2025, Million USD

TABLE 26.    North America Insulin Market Value, By Country, 2026-2030, Million USD

TABLE 27.    Europe Insulin Market Value, By Country, 2020-2025, Million USD

TABLE 28.    Europe Insulin Market Value, By Country, 2026-2030, Million USD

TABLE 29.    Asia-Pacific Insulin Market Value, By Country, 2020-2025, Million USD

TABLE 30.    Asia-Pacific Insulin Market Value, By Country, 2026-2030, Million USD

TABLE 31.    Rest of the World Insulin Market Value, By Country, 2020-2025, Million USD

TABLE 32.    Rest of the World Insulin Market Value, By Country, 2026-2030, Million USD

TABLE 33.    Growth and Coagulation Factor Market Value, By Region, 2020-2025, Million USD

TABLE 34.    Growth and Coagulation Factor Market Value, By Region, 2026-2030, Million USD

TABLE 35.    North America Growth and Coagulation Factor Market Value, By Country, 2020-2025, Million USD

TABLE 36.    North America Growth and Coagulation Factor Market Value, By Country, 2026-2030, Million USD

TABLE 37.    Europe Growth and Coagulation Factor Market Value, By Country, 2020-2025, Million USD

TABLE 38.    Europe Growth and Coagulation Factor Market Value, By Country, 2026-2030, Million USD

TABLE 39.    Asia-Pacific Growth and Coagulation Factor Market Value, By Country, 2020-2025, Million USD

TABLE 40.    Asia-Pacific Growth and Coagulation Factor Market Value, By Country, 2026-2030, Million USD

TABLE 41.    Rest of the World Growth and Coagulation Factor Market Value, By Country, 2020-2025, Million USD

TABLE 42.    Rest of the World Growth and Coagulation Factor Market Value, By Country, 2026-2030, Million USD

TABLE 43.    Erythropoietin Market Value, By Region, 2020-2025, Million USD

TABLE 44.    Erythropoietin Market Value, By Region, 2026-2030, Million USD

TABLE 45.    North America Erythropoietin Market Value, By Country, 2020-2025, Million USD

TABLE 46.    North America Erythropoietin Market Value, By Country, 2026-2030, Million USD

TABLE 47.    Europe Erythropoietin Market Value, By Country, 2020-2025, Million USD

TABLE 48.    Europe Erythropoietin Market Value, By Country, 2026-2030, Million USD

TABLE 49.    Asia-Pacific Erythropoietin Market Value, By Country, 2020-2025, Million USD

TABLE 50.    Asia-Pacific Erythropoietin Market Value, By Country, 2026-2030, Million USD

TABLE 51.    Rest of the World Erythropoietin Market Value, By Country, 2020-2025, Million USD

TABLE 52.    Rest of the World Erythropoietin Market Value, By Country, 2026-2030, Million USD

TABLE 53.    Vaccine Market Value, By Region, 2020-2025, Million USD

TABLE 54.    Vaccine Market Value, By Region, 2026-2030, Million USD

TABLE 55.    North America Vaccine Market Value, By Country, 2020-2025, Million USD

TABLE 56.    North America Vaccine Market Value, By Country, 2026-2030, Million USD

TABLE 57.    Europe Vaccine Market Value, By Country, 2020-2025, Million USD

TABLE 58.    Europe Vaccine Market Value, By Country, 2026-2030, Million USD

TABLE 59.    Asia-Pacific Vaccine Market Value, By Country, 2020-2025, Million USD

TABLE 60.    Asia-Pacific Vaccine Market Value, By Country, 2026-2030, Million USD

TABLE 61.    Rest of the World Vaccine Market Value, By Country, 2020-2025, Million USD

TABLE 62.    Rest of the World Vaccine Market Value, By Country, 2026-2030, Million USD

TABLE 63.    Hormone Market Value, By Region, 2020-2025, Million USD

TABLE 64.    Hormone Market Value, By Region, 2026-2030, Million USD

TABLE 65.    North America Hormone Market Value, By Country, 2020-2025, Million USD

TABLE 66.    North America Hormone Market Value, By Country, 2026-2030, Million USD

TABLE 67.    Europe Hormone Market Value, By Country, 2020-2025, Million USD

TABLE 68.    Europe Hormone Market Value, By Country, 2026-2030, Million USD

TABLE 69.    Asia-Pacific Hormone Market Value, By Country, 2020-2025, Million USD

TABLE 70.    Asia-Pacific Hormone Market Value, By Country, 2026-2030, Million USD

TABLE 71.    Rest of the World Hormone Market Value, By Country, 2020-2025, Million USD

TABLE 72.    Rest of the World Hormone Market Value, By Country, 2026-2030, Million USD

TABLE 73.    Others  Market Value, By Region, 2020-2025, Million USD

TABLE 74.    Others  Market Value, By Region, 2026-2030, Million USD

TABLE 75.    North America Others  Market Value, By Country, 2020-2025, Million USD

TABLE 76.    North America Others  Market Value, By Country, 2026-2030, Million USD

TABLE 77.    Europe Others  Market Value, By Country, 2020-2025, Million USD

TABLE 78.    Europe Others  Market Value, By Country, 2026-2030, Million USD

TABLE 79.    Asia-Pacific Others  Market Value, By Country, 2020-2025, Million USD

TABLE 80.    Asia-Pacific Others  Market Value, By Country, 2026-2030, Million USD

TABLE 81.    Rest of the World Others  Market Value, By Country, 2020-2025, Million USD

TABLE 82.    Rest of the World Others  Market Value, By Country, 2026-2030, Million USD

TABLE 83.    Global Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 84.    Global Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 85.    Oncology Market Value, By Region, 2020-2025, Million USD

TABLE 86.    Oncology Market Value, By Region, 2026-2030, Million USD

TABLE 87.    North America Oncology Market Value, By Country, 2020-2025, Million USD

TABLE 88.    North America Oncology Market Value, By Country, 2026-2030, Million USD

TABLE 89.    Europe Oncology Market Value, By Country, 2020-2025, Million USD

TABLE 90.    Europe Oncology Market Value, By Country, 2026-2030, Million USD

TABLE 91.    Asia-Pacific Oncology Market Value, By Country, 2020-2025, Million USD

TABLE 92.    Asia-Pacific Oncology Market Value, By Country, 2026-2030, Million USD

TABLE 93.    Rest of the World Oncology Market Value, By Country, 2020-2025, Million USD

TABLE 94.    Rest of the World Oncology Market Value, By Country, 2026-2030, Million USD

TABLE 95.    Blood Disorder Market Value, By Region, 2020-2025, Million USD

TABLE 96.    Blood Disorder Market Value, By Region, 2026-2030, Million USD

TABLE 97.    North America Blood Disorder Market Value, By Country, 2020-2025, Million USD

TABLE 98.    North America Blood Disorder Market Value, By Country, 2026-2030, Million USD

TABLE 99.    Europe Blood Disorder Market Value, By Country, 2020-2025, Million USD

TABLE 100.  Europe Blood Disorder Market Value, By Country, 2026-2030, Million USD

TABLE 101.  Asia-Pacific Blood Disorder Market Value, By Country, 2020-2025, Million USD

TABLE 102.  Asia-Pacific Blood Disorder Market Value, By Country, 2026-2030, Million USD

TABLE 103.  Rest of the World Blood Disorder Market Value, By Country, 2020-2025, Million USD

TABLE 104.  Rest of the World Blood Disorder Market Value, By Country, 2026-2030, Million USD

TABLE 105.  Metabolic Disease Market Value, By Region, 2020-2025, Million USD

TABLE 106.  Metabolic Disease Market Value, By Region, 2026-2030, Million USD

TABLE 107.  North America Metabolic Disease Market Value, By Country, 2020-2025, Million USD

TABLE 108.  North America Metabolic Disease Market Value, By Country, 2026-2030, Million USD

TABLE 109.  Europe Metabolic Disease Market Value, By Country, 2020-2025, Million USD

TABLE 110.  Europe Metabolic Disease Market Value, By Country, 2026-2030, Million USD

TABLE 111.  Asia-Pacific Metabolic Disease Market Value, By Country, 2020-2025, Million USD

TABLE 112.  Asia-Pacific Metabolic Disease Market Value, By Country, 2026-2030, Million USD

TABLE 113.  Rest of the World Metabolic Disease Market Value, By Country, 2020-2025, Million USD

TABLE 114.  Rest of the World Metabolic Disease Market Value, By Country, 2026-2030, Million USD

TABLE 115.  Infectious Disease Market Value, By Region, 2020-2025, Million USD

TABLE 116.  Infectious Disease Market Value, By Region, 2026-2030, Million USD

TABLE 117.  North America Infectious Disease Market Value, By Country, 2020-2025, Million USD

TABLE 118.  North America Infectious Disease Market Value, By Country, 2026-2030, Million USD

TABLE 119.  Europe Infectious Disease Market Value, By Country, 2020-2025, Million USD

TABLE 120.  Europe Infectious Disease Market Value, By Country, 2026-2030, Million USD

TABLE 121.  Asia-Pacific Infectious Disease Market Value, By Country, 2020-2025, Million USD

TABLE 122.  Asia-Pacific Infectious Disease Market Value, By Country, 2026-2030, Million USD

TABLE 123.  Rest of the World Infectious Disease Market Value, By Country, 2020-2025, Million USD

TABLE 124.  Rest of the World Infectious Disease Market Value, By Country, 2026-2030, Million USD

TABLE 125.  Cardiovascular Disease Market Value, By Region, 2020-2025, Million USD

TABLE 126.  Cardiovascular Disease Market Value, By Region, 2026-2030, Million USD

TABLE 127.  North America Cardiovascular Disease Market Value, By Country, 2020-2025, Million USD

TABLE 128.  North America Cardiovascular Disease Market Value, By Country, 2026-2030, Million USD

TABLE 129.  Europe Cardiovascular Disease Market Value, By Country, 2020-2025, Million USD

TABLE 130.  Europe Cardiovascular Disease Market Value, By Country, 2026-2030, Million USD

TABLE 131.  Asia-Pacific Cardiovascular Disease Market Value, By Country, 2020-2025, Million USD

TABLE 132.  Asia-Pacific Cardiovascular Disease Market Value, By Country, 2026-2030, Million USD

TABLE 133.  Rest of the World Cardiovascular Disease Market Value, By Country, 2020-2025, Million USD

TABLE 134.  Rest of the World Cardiovascular Disease Market Value, By Country, 2026-2030, Million USD

TABLE 135.  Neurological Disease Market Value, By Region, 2020-2025, Million USD

TABLE 136.  Neurological Disease Market Value, By Region, 2026-2030, Million USD

TABLE 137.  North America Neurological Disease Market Value, By Country, 2020-2025, Million USD

TABLE 138.  North America Neurological Disease Market Value, By Country, 2026-2030, Million USD

TABLE 139.  Europe Neurological Disease Market Value, By Country, 2020-2025, Million USD

TABLE 140.  Europe Neurological Disease Market Value, By Country, 2026-2030, Million USD

TABLE 141.  Asia-Pacific Neurological Disease Market Value, By Country, 2020-2025, Million USD

TABLE 142.  Asia-Pacific Neurological Disease Market Value, By Country, 2026-2030, Million USD

TABLE 143.  Rest of the World Neurological Disease Market Value, By Country, 2020-2025, Million USD

TABLE 144.  Rest of the World Neurological Disease Market Value, By Country, 2026-2030, Million USD

TABLE 145.  Immunology Market Value, By Region, 2020-2025, Million USD

TABLE 146.  Immunology Market Value, By Region, 2026-2030, Million USD

TABLE 147.  North America Immunology Market Value, By Country, 2020-2025, Million USD

TABLE 148.  North America Immunology Market Value, By Country, 2026-2030, Million USD

TABLE 149.  Europe Immunology Market Value, By Country, 2020-2025, Million USD

TABLE 150.  Europe Immunology Market Value, By Country, 2026-2030, Million USD

TABLE 151.  Asia-Pacific Immunology Market Value, By Country, 2020-2025, Million USD

TABLE 152.  Asia-Pacific Immunology Market Value, By Country, 2026-2030, Million USD

TABLE 153.  Rest of the World Immunology Market Value, By Country, 2020-2025, Million USD

TABLE 154.  Rest of the World Immunology Market Value, By Country, 2026-2030, Million USD

TABLE 155.  Other Diseases Market Value, By Region, 2020-2025, Million USD

TABLE 156.  Other Diseases Market Value, By Region, 2026-2030, Million USD

TABLE 157.  North America Other Diseases Market Value, By Country, 2020-2025, Million USD

TABLE 158.  North America Other Diseases Market Value, By Country, 2026-2030, Million USD

TABLE 159.  Europe Other Diseases Market Value, By Country, 2020-2025, Million USD

TABLE 160.  Europe Other Diseases Market Value, By Country, 2026-2030, Million USD

TABLE 161.  Asia-Pacific Other Diseases Market Value, By Country, 2020-2025, Million USD

TABLE 162.  Asia-Pacific Other Diseases Market Value, By Country, 2026-2030, Million USD

TABLE 163.  Rest of the World Other Diseases Market Value, By Country, 2020-2025, Million USD

TABLE 164.  Rest of the World Other Diseases Market Value, By Country, 2026-2030, Million USD

TABLE 165.  Global Biopharmaceuticals Market Value, By Region, 2020-2025, Million USD

TABLE 166.  Global Biopharmaceuticals Market Value, By Region, 2026-2030, Million USD

TABLE 167.  North America Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 168.  North America Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 169.  North America Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 170.  North America Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 171.  North America Biopharmaceuticals Market Value, By Country, 2020-2025, Million USD

TABLE 172.  North America Biopharmaceuticals Market Value, By Country, 2026-2030, Million USD

TABLE 173.  U.S. Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 174.  U.S. Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 175.  U.S. Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 176.  U.S. Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 177.  Canada Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 178.  Canada Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 179.  Canada Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 180.  Canada Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 181.  Mexico Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 182.  Mexico Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 183.  Mexico Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 184.  Mexico Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 185.  Europe Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 186.  Europe Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 187.  Europe Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 188.  Europe Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 189.  Europe Biopharmaceuticals Market Value, By Country, 2020-2025, Million USD

TABLE 190.  Europe Biopharmaceuticals Market Value, By Country, 2026-2030, Million USD

TABLE 191.  UK Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 192.  UK Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 193.  UK Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 194.  UK Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 195.  Germany Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 196.  Germany Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 197.  Germany Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 198.  Germany Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 199.  France Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 200.  France Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 201.  France Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 202.  France Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 203.  Spain Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 204.  Spain Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 205.  Spain Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 206.  Spain Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 207.  Italy Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 208.  Italy Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 209.  Italy Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 210.  Italy Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 211.  Netherlands Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 212.  Netherlands Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 213.  Netherlands Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 214.  Netherlands Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 215.  Rest of Europe Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 216.  Rest of Europe Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 217.  Rest of Europe Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 218.  Rest of Europe Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 219.  Asia-Pacific Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 220.  Asia-Pacific Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 221.  Asia-Pacific Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 222.  Asia-Pacific Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 223.  Asia-Pacific Biopharmaceuticals Market Value, By Country, 2020-2025, Million USD

TABLE 224.  Asia-Pacific Biopharmaceuticals Market Value, By Country, 2026-2030, Million USD

TABLE 225.  China Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 226.  China Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 227.  China Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 228.  China Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 229.  Japan Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 230.  Japan Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 231.  Japan Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 232.  Japan Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 233.  India Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 234.  India Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 235.  India Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 236.  India Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 237.  Australia Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 238.  Australia Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 239.  Australia Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 240.  Australia Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 241.  South Korea Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 242.  South Korea Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 243.  South Korea Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 244.  South Korea Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 245.  Singapore Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 246.  Singapore Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 247.  Singapore Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 248.  Singapore Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 249.  Indonesia Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 250.  Indonesia Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 251.  Indonesia Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 252.  Indonesia Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 253.  Rest of Asia-Pacific Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 254.  Rest of Asia-Pacific Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 255.  Rest of Asia-Pacific Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 256.  Rest of Asia-Pacific Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 257.  Rest of the World Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 258.  Rest of the World Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 259.  Rest of the World Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 260.  Rest of the World Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 261.  Rest of the World Biopharmaceuticals Market Value, By Country, 2020-2025, Million USD

TABLE 262.  Rest of the World Biopharmaceuticals Market Value, By Country, 2026-2030, Million USD

TABLE 263.  Latin America Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 264.  Latin America Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 265.  Latin America Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 266.  Latin America Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 267.  Middle East Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 268.  Middle East Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 269.  Middle East Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 270.  Middle East Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 271.  Africa Biopharmaceuticals Market Value, By Product, 2020-2025, Million USD

TABLE 272.  Africa Biopharmaceuticals Market Value, By Product, 2026-2030, Million USD

TABLE 273.  Africa Biopharmaceuticals Market Value, By Application, 2020-2025, Million USD

TABLE 274.  Africa Biopharmaceuticals Market Value, By Application, 2026-2030, Million USD

TABLE 275.  Abbott Laboratories: COMPANY SNAPSHOT

TABLE 276.  Abbott Laboratories: operating segments

TABLE 277.  Abbott Laboratories: PRODUCT PORTFOLIO

TABLE 278.  Abbott Laboratories: BUSINESS SEGMENT

TABLE 279.  Abbott Laboratories: GEOGRAPHIC SEGMENT

TABLE 280.  Abbott Laboratories: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 281.  Amgen Inc: COMPANY SNAPSHOT

TABLE 282.  Amgen Inc: PRODUCT PORTFOLIO

TABLE 283.  Amgen Inc: GEOGRAPHIC SEGMENT

TABLE 284.  Amgen Inc: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 285.  Biogen: COMPANY SNAPSHOT

TABLE 286.  Biogen: PRODUCT PORTFOLIO

TABLE 287.  Biogen: GEOGRAPHIC SEGMENT

TABLE 288.  Biogen: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 289.  Lilly: COMPANY SNAPSHOT

TABLE 290.  Lilly: PRODUCT PORTFOLIO

TABLE 291.  Lilly: GEOGRAPHIC SEGMENT

TABLE 292.  Lilly: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 293.  F. Hoffmann-La Roche Ltd: COMPANY SNAPSHOT

TABLE 294.  F. Hoffmann-La Roche Ltd: operating segments

TABLE 295.  F. Hoffmann-La Roche Ltd: PRODUCT PORTFOLIO

TABLE 296.  F. Hoffmann-La Roche Ltd: BUSINESS SEGMENT

TABLE 297.  F. Hoffmann-La Roche Ltd: GEOGRAPHIC SEGMENT

TABLE 298.  F. Hoffmann-La Roche Ltd: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 299.  Johnson & Johnson Services, Inc.: COMPANY SNAPSHOT

TABLE 300.  Johnson & Johnson Services, Inc.: operating segments

TABLE 301.  Johnson & Johnson Services, Inc.: PRODUCT PORTFOLIO

TABLE 302.  Johnson & Johnson Services, Inc.: BUSINESS SEGMENT

TABLE 303.  Johnson & Johnson Services, Inc.: GEOGRAPHIC SEGMENT

TABLE 304.  Johnson & Johnson Services, Inc.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 305.  Merck & Co., Inc: COMPANY SNAPSHOT

TABLE 306.  Merck & Co., Inc: operating segments

TABLE 307.  Merck & Co., Inc: PRODUCT PORTFOLIO

TABLE 308.  Merck & Co., Inc: BUSINESS SEGMENT

TABLE 309.  Merck & Co., Inc: GEOGRAPHIC SEGMENT

TABLE 310.  Merck & Co., Inc: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 311.  Novo Nordisk A/S: COMPANY SNAPSHOT

TABLE 312.  Novo Nordisk A/S: operating segments

TABLE 313.  Novo Nordisk A/S: PRODUCT PORTFOLIO

TABLE 314.  Novo Nordisk A/S: BUSINESS SEGMENT

TABLE 315.  Novo Nordisk A/S: GEOGRAPHIC SEGMENT

TABLE 316.  Novo Nordisk A/S: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 317.  Pfizer Inc: COMPANY SNAPSHOT

TABLE 318.  Pfizer Inc: PRODUCT PORTFOLIO

TABLE 319.  Pfizer Inc: GEOGRAPHIC SEGMENT

TABLE 320.  Pfizer Inc: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 321.  Sanofi: COMPANY SNAPSHOT

TABLE 322.  Sanofi: operating segments

TABLE 323.  Sanofi: PRODUCT PORTFOLIO

TABLE 324.  Sanofi: BUSINESS SEGMENT

TABLE 325.  Sanofi: GEOGRAPHIC SEGMENT

TABLE 326.  Sanofi: PRODUCT PORTFOLIO

TABLE 327.  AstraZeneca: COMPANY SNAPSHOT

TABLE 328.  AstraZeneca: PRODUCT PORTFOLIO

TABLE 329.  AstraZeneca: GEOGRAPHIC SEGMENT

TABLE 330.  AstraZeneca: PRODUCT PORTFOLIO

TABLE 331.  Moderna, Inc.: COMPANY SNAPSHOT

TABLE 332.  Moderna, Inc.: PRODUCT PORTFOLIO

 

 

 

LIST OF FIGURES

FIGURE 1.     Market share analysis of top 10 BIOPHARMACEUTICAL PROVIDERS, 2020

FIGURE 2.     Global Biopharmaceuticals Market Value, By Product, 2020-2030, Million USD

FIGURE 3.     Monoclonal antibody Market Value, By Region, 2020-2030, Million USD

FIGURE 4.     North America Monoclonal antibody Market Value, By Country, 2020-2030, Million USD

FIGURE 5.     Europe Monoclonal antibody Market Value, By Country, 2020-2030, Million USD

FIGURE 6.     Asia-Pacific Monoclonal antibody Market Value, By Country, 2020-2030, Million USD

FIGURE 7.     Rest of the World Monoclonal antibody Market Value, By Country, 2020-2030, Million USD

FIGURE 8.     Interferon Market Value, By Region, 2020-2030, Million USD

FIGURE 9.     North America Interferon Market Value, By Country, 2020-2030, Million USD

FIGURE 10.  Europe Interferon Market Value, By Country, 2020-2030, Million USD

FIGURE 11.  Asia-Pacific Interferon Market Value, By Country, 2020-2030, Million USD

FIGURE 12.  Rest of the World Interferon Market Value, By Country, 2020-2030, Million USD

FIGURE 13.  Insulin Market Value, By Region, 2020-2030, Million USD

FIGURE 14.  North America Insulin Market Value, By Country, 2020-2030, Million USD

FIGURE 15.  Europe Insulin Market Value, By Country, 2020-2030, Million USD

FIGURE 16.  Asia-Pacific Insulin Market Value, By Country, 2020-2030, Million USD

FIGURE 17.  Rest of the World Insulin Market Value, By Country, 2020-2030, Million USD

FIGURE 18.  Growth and Coagulation Factor Market Value, By Region, 2020-2030, Million USD

FIGURE 19.  North America Growth and Coagulation Factor Market Value, By Country, 2020-2030, Million USD

FIGURE 20.  Europe Growth and Coagulation Factor Market Value, By Country, 2020-2030, Million USD

FIGURE 21.  Asia-Pacific Growth and Coagulation Factor Market Value, By Country, 2020-2030, Million USD

FIGURE 22.  Rest of the World Growth and Coagulation Factor Market Value, By Country, 2020-2030, Million USD

FIGURE 23.  Erythropoietin Market Value, By Region, 2020-2030, Million USD

FIGURE 24.  North America Erythropoietin Market Value, By Country, 2020-2030, Million USD

FIGURE 25.  Europe Erythropoietin Market Value, By Country, 2020-2030, Million USD

FIGURE 26.  Asia-Pacific Erythropoietin Market Value, By Country, 2020-2030, Million USD

FIGURE 27.  Rest of the World Erythropoietin Market Value, By Country, 2020-2030, Million USD

FIGURE 28.  Vaccine Market Value, By Region, 2020-2030, Million USD

FIGURE 29.  North America Vaccine Market Value, By Country, 2020-2030, Million USD

FIGURE 30.  Europe Vaccine Market Value, By Country, 2020-2030, Million USD

FIGURE 31.  Asia-Pacific Vaccine Market Value, By Country, 2020-2030, Million USD

FIGURE 32.  Rest of the World Vaccine Market Value, By Country, 2020-2030, Million USD

FIGURE 33.  Hormone Market Value, By Region, 2020-2030, Million USD

FIGURE 34.  North America Hormone Market Value, By Country, 2020-2030, Million USD

FIGURE 35.  Europe Hormone Market Value, By Country, 2020-2030, Million USD

FIGURE 36.  Asia-Pacific Hormone Market Value, By Country, 2020-2030, Million USD

FIGURE 37.  Rest of the World Hormone Market Value, By Country, 2020-2030, Million USD

FIGURE 38.  Others  Market Value, By Region, 2020-2030, Million USD

FIGURE 39.  North America Others  Market Value, By Country, 2020-2030, Million USD

FIGURE 40.  Europe Others  Market Value, By Country, 2020-2030, Million USD

FIGURE 41.  Asia-Pacific Others  Market Value, By Country, 2020-2030, Million USD

FIGURE 42.  Rest of the World Others  Market Value, By Country, 2020-2030, Million USD

FIGURE 43.  Global Biopharmaceuticals Market Value, By Application, 2020-2030, Million USD

FIGURE 44.  Oncology Market Value, By Region, 2020-2030, Million USD

FIGURE 45.  North America Oncology Market Value, By Country, 2020-2030, Million USD

FIGURE 46.  Europe Oncology Market Value, By Country, 2020-2030, Million USD

FIGURE 47.  Asia-Pacific Oncology Market Value, By Country, 2020-2030, Million USD

FIGURE 48.  Rest of the World Oncology Market Value, By Country, 2020-2030, Million USD

FIGURE 49.  Blood Disorder Market Value, By Region, 2020-2030, Million USD

FIGURE 50.  North America Blood Disorder Market Value, By Country, 2020-2030, Million USD

FIGURE 51.  Europe Blood Disorder Market Value, By Country, 2020-2030, Million USD

FIGURE 52.  Asia-Pacific Blood Disorder Market Value, By Country, 2020-2030, Million USD

FIGURE 53.  Rest of the World Blood Disorder Market Value, By Country, 2020-2030, Million USD

FIGURE 54.  Metabolic Disease Market Value, By Region, 2020-2030, Million USD

FIGURE 55.  North America Metabolic Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 56.  Europe Metabolic Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 57.  Asia-Pacific Metabolic Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 58.  Rest of the World Metabolic Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 59.  Infectious Disease Market Value, By Region, 2020-2030, Million USD

FIGURE 60.  North America Infectious Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 61.  Europe Infectious Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 62.  Asia-Pacific Infectious Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 63.  Rest of the World Infectious Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 64.  Cardiovascular Disease Market Value, By Region, 2020-2030, Million USD

FIGURE 65.  North America Cardiovascular Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 66.  Europe Cardiovascular Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 67.  Asia-Pacific Cardiovascular Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 68.  Rest of the World Cardiovascular Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 69.  Neurological Disease Market Value, By Region, 2020-2030, Million USD

FIGURE 70.  North America Neurological Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 71.  Europe Neurological Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 72.  Asia-Pacific Neurological Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 73.  Rest of the World Neurological Disease Market Value, By Country, 2020-2030, Million USD

FIGURE 74.  Immunology Market Value, By Region, 2020-2030, Million USD

FIGURE 75.  North America Immunology Market Value, By Country, 2020-2030, Million USD

FIGURE 76.  Europe Immunology Market Value, By Country, 2020-2030, Million USD

FIGURE 77.  Asia-Pacific Immunology Market Value, By Country, 2020-2030, Million USD

FIGURE 78.  Rest of the World Immunology Market Value, By Country, 2020-2030, Million USD

FIGURE 79.  Other Diseases Market Value, By Region, 2020-2030, Million USD

FIGURE 80.  North America Other Diseases Market Value, By Country, 2020-2030, Million USD

FIGURE 81.  Europe Other Diseases Market Value, By Country, 2020-2030, Million USD

FIGURE 82.  Asia-Pacific Other Diseases Market Value, By Country, 2020-2030, Million USD

FIGURE 83.  Rest of the World Other Diseases Market Value, By Country, 2020-2030, Million USD

FIGURE 84.  Global Biopharmaceuticals Market Value, By Region, 2020-2030, Million USD

FIGURE 85.  North America Biopharmaceuticals Market Value, By Product, 2020-2030, Million USD

FIGURE 86.  North America Biopharmaceuticals Market Value, By Application, 2020-2030, Million USD

FIGURE 87.  North America Biopharmaceuticals Market Value, By Country, 2020-2030, Million USD

FIGURE 88.  U.S. Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 89.  U.S. Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 90.  Canada Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 91.  Canada Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 92.  Mexico Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 93.  Mexico Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 94.  Europe Biopharmaceuticals Market Value, By Product, 2020-2030, Million USD

FIGURE 95.  Europe Biopharmaceuticals Market Value, By Application, 2020-2030, Million USD

FIGURE 96.  Europe Biopharmaceuticals Market Value, By Country, 2020-2030, Million USD

FIGURE 97.  UK Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 98.  UK Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 99.  Germany Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 100.                        Germany Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 101.                        France Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 102.                        France Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 103.                        Spain Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 104.                        Spain Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 105.                        Italy Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 106.                        Italy Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 107.                        Netherlands Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 108.                        Netherlands Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 109.                        Rest of Europe Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 110.                        Rest of Europe Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 111.                        Asia-Pacific Biopharmaceuticals Market Value, By Product, 2020-2030, Million USD

FIGURE 112.                        Asia-Pacific Biopharmaceuticals Market Value, By Application, 2020-2030, Million USD

FIGURE 113.                        Asia-Pacific Biopharmaceuticals Market Value, By Country, 2020-2030, Million USD

FIGURE 114.                        China Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 115.                        China Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 116.                        Japan Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 117.                        Japan Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 118.                        India Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 119.                        India Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 120.                        Australia Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 121.                        Australia Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 122.                        South Korea Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 123.                        South Korea Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 124.                        Singapore Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 125.                        Singapore Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 126.                        Indonesia Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 127.                        Indonesia Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 128.                        Rest of Asia-Pacific Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 129.                        Rest of Asia-Pacific Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 130.                        Rest of the World Biopharmaceuticals Market Value, By Product, 2020-2030, Million USD

FIGURE 131.                        Rest of the World Biopharmaceuticals Market Value, By Application, 2020-2030, Million USD

FIGURE 132.                        Rest of the World Biopharmaceuticals Market Value, By Country, 2020-2030, Million USD

FIGURE 133.                        Latin America Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 134.                        Latin America Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 135.                        Middle East Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 136.                        Middle East Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 137.                        Africa Biopharmaceuticals Market, By Product, 2020-2030, Million USD

FIGURE 138.                        Africa Biopharmaceuticals Market, By Application, 2020-2030, Million USD

FIGURE 139.                        Abbott Laboratories: NET SALES, 2018–2020 ($Million)

FIGURE 140.                        Abbott Laboratories: Primary Market Competitors

FIGURE 141.                        Amgen Inc: NET SALES, 2018–2020 ($Million)

FIGURE 142.                        Amgen Inc: Primary Market Competitors

Amgen Inc Primary Market Competitors

FIGURE 143.                        Biogen: NET SALES, 2018–2020 ($Million)

FIGURE 144.                        Biogen: Primary Market Competitors

FIGURE 145.                        Lilly: NET SALES, 2018–2020 ($Million)

FIGURE 146.                        Lilly: Primary Market Competitors

FIGURE 147.                        F. Hoffmann-La Roche Ltd: NET SALES, 2018–2020 ($Million)

FIGURE 148.                        F. Hoffmann-La Roche Ltd: Primary Market Competitors

FIGURE 149.                        Johnson & Johnson Services, Inc.: NET SALES, 2018–2020 ($Million)

FIGURE 150.                        Johnson & Johnson Services, Inc.: Primary Market Competitors

FIGURE 151.                        Merck & Co., Inc: NET SALES, 2018–2020 ($Million)

FIGURE 152.                        Merck & Co.: Primary Market Competitors

FIGURE 153.                        Novo Nordisk A/S: NET SALES, 2018–2020 ($Million)

FIGURE 154.                        Novo Nordisk A/S: Primary Market Competitors

FIGURE 155.                        Pfizer Inc: NET SALES, 2018–2020 ($Million)

FIGURE 156.                        Pfizer Inc: Primary Market Competitors

FIGURE 157.                        Sanofi: NET SALES, 2018–2020 ($Million)

FIGURE 158.                        Sanofi: Primary Market Competitors

FIGURE 159.                        AstraZeneca: NET SALES, 2018–2020 ($Million)

FIGURE 160.                        AstraZeneca: Primary Market Competitors

FIGURE 161.                        Moderna, Inc.: NET SALES, 2018–2020 ($Million)

FIGURE 162.                        Moderna, Inc.: Primary Market Competitors

KEY PLAYERS

  • Abbott Laboratories
  • Amgen Inc.
  • Biogen
  • Lilly
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk
  • Pfizer Inc.
  • Safoni
  • AstraZeneca
  • Moderna

Frequently Asked Questions
What will be the worth of global Biopharmaceutical market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Biopharmaceutical market business is expected to hit at $974.48 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Biopharmaceutical Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Biopharmaceutical industry?

Abbott Laboratories, Amgen Inc., Biogen, Lilly, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk, Pfizer Inc., Safoni, AstraZeneca, and Moderna.

What are the market segmentations and scope of the study?

The global Biopharmaceutical market share analysis is based on product, application, and geography.

How big is the Biopharmaceutical market?

Currently (in 2021), the market value stands at USD 291.41 billion and it is anticipated to reach USD 974.48 billion by 2030.